Tumor progression and metastasis

被引:284
作者
Yokota, J [1 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Biol, Chuo Ku, Tokyo 1040045, Japan
关键词
D O I
10.1093/carcin/21.3.497
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is now widely accepted that cancer is attributed to the accumulation of genetic alterations in cells. Thus, to understand the molecular mechanisms of cancer metastasis, it is indispensable to identify the genes whose alterations accumulate during cancer progression as well as the genes whose expression is responsible for the acquisition of metastatic potential in cancer cells. Molecular analyses of cancer cells in various stages of progression have revealed that alterations in tumor suppressor genes and oncogenes accumulate during tumor progression and correlate with the clinical aggressiveness of cancer. Comparative analyses of gene expression profiles between metastatic and nonmetastatic cells have revealed that various genes are differentially expressed in association with the metastatic potential of cancer cells. A number of genes have been also identified as having functions in inducing or suppressing metastasis in experimental models. However, the association between causative genetic alterations and resulting phenotypic alterations with respect to the metastatic potential of cancer cells is not fully understood. Therefore, elucidation of genotype-phenotype correlation will be required to further understand a complex process of metastasis. Here, I review the progress on molecular studies of tumor progression and metastasis of the past 20 years and discuss the future direction in this field of science.
引用
收藏
页码:497 / 503
页数:7
相关论文
共 76 条
[1]  
BERNSTEIN S, 1988, P NATL ACAD SCI USA, V85, P5581
[2]   EXPRESSION OF THE METASTATIC PHENOTYPE IN CELLS TRANSFECTED WITH HUMAN METASTATIC TUMOR DNA [J].
BERNSTEIN, SC ;
WEINBERG, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (06) :1726-1730
[3]   MOLECULAR THEMES IN ONCOGENESIS [J].
BISHOP, JM .
CELL, 1991, 64 (02) :235-248
[4]  
Bouvet M, 1998, CANCER RES, V58, P2288
[5]   AMPLIFICATION OF N-MYC IN UNTREATED HUMAN NEUROBLASTOMAS CORRELATES WITH ADVANCED DISEASE STAGE [J].
BRODEUR, GM ;
SEEGER, RC ;
SCHWAB, M ;
VARMUS, HE ;
BISHOP, JM .
SCIENCE, 1984, 224 (4653) :1121-1124
[6]   EXPRESSION OF RECESSIVE ALLELES BY CHROMOSOMAL MECHANISMS IN RETINOBLASTOMA [J].
CAVENEE, WK ;
DRYJA, TP ;
PHILLIPS, RA ;
BENEDICT, WF ;
GODBOUT, R ;
GALLIE, BL ;
MURPHREE, AL ;
STRONG, LC ;
WHITE, RL .
NATURE, 1983, 305 (5937) :779-784
[7]   Essential role for oncogenic Ras in tumour maintenance [J].
Chin, L ;
Tam, A ;
Pomerantz, J ;
Wong, M ;
Holash, J ;
Bardeesy, N ;
Shen, Q ;
O'Hagan, R ;
Pantginis, J ;
Zhou, H ;
Horner, JW ;
Cordon-Cardo, C ;
Yancopoulos, GD ;
DePinho, RA .
NATURE, 1999, 400 (6743) :468-472
[8]  
DAVIS CL, 1993, MATER SCI TECH SER, V9, P8, DOI 10.1179/026708393790171494
[9]   KAI1, A METASTASIS SUPPRESSOR GENE FOR PROSTATE-CANCER ON HUMAN-CHROMOSOME 11P11.2 [J].
DONG, JT ;
LAMB, PW ;
RINKERSCHAEFFER, CW ;
VUKANOVIC, J ;
ICHIKAWA, T ;
ISAACS, JT ;
BARRETT, JC .
SCIENCE, 1995, 268 (5212) :884-886
[10]   Expression profiling using cDNA microarrays [J].
Duggan, DJ ;
Bittner, M ;
Chen, YD ;
Meltzer, P ;
Trent, JM .
NATURE GENETICS, 1999, 21 (Suppl 1) :10-14